Joost S.P Vermaat, MD, PhD, MSc¹, Joshua Brody, MD^2*, Juraj Ďuraš, MD^3*, Yasmin H. Karimi, MD⁴, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc⁵, Justin M. Darrah, MD^6*, Gerardo Musuraca, MD, PhD^7*, Franck Morschhauser, MD, PhD^8*, Daniela Hoehn, MD, PhD^9*, Ali Rana, MD, PhD^9*, Yaou Song, MS^9*, Pegah Jafarinasabian, MD, PhD^10* and David Belada, MD^11*

¹Leiden University Medical Center, Leiden, Netherlands
²Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Hemato-Oncology, University Hospital and Faculty of Medicine, Ostrava, CZE
⁴Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
⁵Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
⁶Cedars-Sinai Medical Center, Los Angeles, CA
⁷IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
⁸University of Lille, CHU Lille, Lille, France
⁹Genmab, Plainsboro, NJ
¹⁰AbbVie, North Chicago, IL
¹¹4th Department of Internal Medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic

Yuqin Song¹, JUN MA^2*, Yan Xie^3*, Huilai Zhang, MD^4*, Zhigang Peng^5*, Yuerong Shuang^6*, Fei Li^7*, Yufu Li^8*, Haiyan Yang^9*, Xiuhua Sun^10*, Liqun Zou^11*, Yunhong Huang^12*, Weili Zhao^13*, Wenrong Huang¹⁴, Hui Zhou^15*, Mingying Liu^16*, Weiwei Wang^16*, Jing Xu^16*, Yajie Wang^16* and Jun Zhu, MD^17*

¹Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China
²Department of Hematology & Oncology, Harbin Institute of Hematology & Oncology, Harbin, China
³Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Minis-try of Education), Peking University Cancer Hospital & Institute, Beijing, China
⁴Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
⁵The First Affiliated Hospital of Guangxi Medical University, Nanning, China
⁶Jiangxi Cancer Hospital, Nanchang, China
⁷The First Affiliated Hospital of Nanchang University, Nanchang, China
⁸Henan Cancer Hospital, Zhengzhou, China
⁹Zhejiang Cancer Hospital, Hangzhou, China
¹⁰The Second Hospital of Dalian Medical University, Dalian, China
¹¹West China Hospital of Sichuan University, Chengdu, China
¹²The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
¹³State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
¹⁴The Fifth Medical Center of the General Hospital of the Chinese People's Liberation Army, Beijing, China
¹⁵Hunan Cancer Hospital, Changsha, China
¹⁶Shanghai Junshi Biosciences, Shanghai, China
¹⁷Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China

Marc Hoffmann, MD¹, Javier L. Munoz², Jason Westin, MD³, Theodoros Vassilakopoulos, PhD^4*, Alejandro Martin Garcia-Sancho, MD^5*, Antonio Rueda Dominguez, MD^6*, Wojciech Jurczak, MD, PhD⁷, Su-Peng Yeh, MD^8*, Maria Bouzani^9*, Argyrios Gkasiamis, MD¹⁰, Mark Kaplan^11*, Arpankumar Patel^11*, Floriane Boucaud^10*, Ju Li^11* and Grzegorz S. Nowakowski, MD¹²

¹The University of Kansas Medical Center, Kansas City, KS
²Department of Hematology, Mayo Clinic, Phoenix, AZ
³Department of Lymphoma-Myeloma, MD Anderson Cancer Center, Houston, TX
⁴Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
⁵Hospital Universitario de Salamanca, Salamanca, Spain
⁶Regional and Virgen de la Victoria University Hospitals, Málaga, Spain
⁷Dpt of Clinical Oncology, MSC National Research Institute of Oncology, Kraków, Poland
⁸Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
⁹Department of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece
¹⁰Bristol Myers Squibb, Boudry, Switzerland
¹¹Bristol Myers Squibb, Princeton, NJ
¹²Department of Internal Medicine, Mayo Clinic, Rochester, MN

Martin Hutchings, MD PhD^1*, Abraham Avigdor, MD², Anna Maria Sureda Balari, MD, PhD³, Maria José Terol, MD, PhD^4*, Francesc Bosch, MD PhD^5*, Paolo Corradini, MD⁶, Thomas S. Larsen^7*, Antonio Rueda Dominguez, MD^8*, Alan Skarbnik, MD⁹, Judit Mészáros Joergensen, MD, PhD^10*, David Lavie^11*, Ronit Gurion, MD^12*, Pier Luigi Zinzani, MD, PhD¹³, Antonio Pinto, MD^14*, Raul Cordoba, MD, PhD¹⁵, Alessia Bottos, PhD^16*, Donghang Li, PhD^17*, James Relf, MD^18*, Audrey Filézac De L'Étang, PhD^16*, Gila Sellam, PhD^16* and Giuseppe Gritti^19*

¹Rigshospitalet, Copenhagen, Denmark
²Sheba Medical Center, Ramat Gan and Tel Aviv University, Tel Aviv, Israel
³Universitat de Barcelona, Barcelona, Spain
⁴Hospital Clínico Universitario INCLIVA, University of Valencia, Valencia, Spain
⁵University Hospital Vall d'Hebron, Barcelona, Spain
⁶Hematology, University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
⁷Odense University Hospital, Odense, Denmark
⁸Regional and Virgen de la Victoria University Hospitals, Málaga, Spain
⁹Novant Health Cancer Institute, Lymphoma and CLL Program, Charlotte, NC
¹⁰Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
¹¹Hadassah Medical Center, Jerusalem, Israel
¹²Rabin Medical Center, Petach Tikva and Tel Aviv University, Tel Aviv, Israel
¹³University of Bologna, Bologna, Italy
¹⁴National Cancer Institute Fondazione G. Pascale IRCCS, Naples, Italy
¹⁵Fundación Jiménez Díaz University Hospital, Madrid, Spain
¹⁶F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁷F. Hoffmann-La Roche Ltd, Shanghai, China
¹⁸Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁹Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy

Jennifer L. Crombie, MD^1*, Matthew Matasar, MD, MS², Max S. Topp, MD^3*, John N. Allan, MD², Jeffrey A. Barnes^4*, Jon E. Arnason, MD⁵, Jean-Marie Michot^6*, Neta Goldschmidt^7*, Susan M. O'Brien⁸, Uri Abadi, MD^9,10*, Irit Avivi Mazza, MD^11*, Jessica Cai^12*, Dina M. Flink¹², Min Zhu^12*, Jurriaan Brouwer-Visser^12*, Hesham Mohamed¹², Aafia Chaudhry¹², Srikanth Ambati^12* and Steve M Ansell¹³

¹Dana Farber Cancer Institute, Boston, MA
²Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
³Universitätsklinikum Würzburg, Würzburg, Germany
⁴Massachusetts General Hospital Cancer Center, Boston, MA
⁵Beth Israel Deaconess Medical Center, Boston, MA
⁶Gustave Roussy Cancer Campus, Villejuif, France
⁷Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
⁸Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA
⁹Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
¹⁰Hematology Institute, Meir Medical Center, Kfar Saba, Israel
¹¹Ichilov University Hospital, Tel-Aviv, Israel
¹²Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹³Mayo Clinic, Rochester, MN

Oluwatobi Odetola, MD¹, Shuo Ma, MD, PhD², Jane N. Winter, MD², Barbara Pro, MD², Ishan Roy, MD, PhD³, Ping Xie, MD, PhD^4*, Bin Zhang, MD, PhD^4*, George Koulogeorgas^5*, Xinlei Mi, PhD^6*, Robert Bayer, MD^7*, Robert Eisner, DO⁷, Valerie Nelson, MD^7*, Habib Shaikh, DO^7*, Dean Tsarwhas, MD^7*, Faisal Saghir, MD^7*, Parameswaran Venugopal, MD⁸, Leo I. Gordon, MD² and Reem Karmali, MD, MSc⁹

¹Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Maywood, IL
²Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
³Shirley Ryan Ability Lab, Chicago, IL
⁴Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL
⁵Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁶Department of Preventative Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
⁷Feinberg School of Medicine, Northwestern University, Chicago, IL
⁸Rush University Medical Center, Chicago, IL
⁹Northwestern University, Chicago, IL

Alexey Danilov, MD¹, Michael T. Tees, MD², Krish Patel^3*, William G. Wierda, MD, PhD⁴, Manish Patel, MD^5*, Ian W. Flinn, MD, PhD⁶, Tahir Latif⁷, Weiyun Ai⁸, Meghan C. Thompson, MD⁹, Michael L. Wang, MD¹⁰, Clare Sun, MD¹¹, Deborah M. Stephens, DO¹², Michael Thirman¹³, Melissa Gessner^14*, Johannes Wolff^14*, Amanda Schwab^14*, May Tan^14*, Daniel Chan^14*, Erin Meredith^14* and Adrian Wiestner, MD¹⁵

¹Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA
²The Colorado Blood Cancer Institute a part of Sarah Cannon Cancer Institute at Presbyterian/St Luke's Medical Center, Denver, CO
³Swedish Cancer Institute, Seattle, WA
⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL
⁶Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN
⁷University of Cincinnati Medical Center, Cincinnati, OH
⁸University of California San Francisco, San Francisco, CA
⁹Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
¹²Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹³Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁴Nurix Therapeutics, Inc., San Francisco, CA
¹⁵Hematology Branch, National Heart, Lung, and Blood Institute, NIH, NHLBI, Bethesda, MD

Tomomi Toubai, MD, PhD¹, Junya Kuroda, MD, PhD², Youko Suehiro, MD, PhD^3*, Yuko Mishima, PhD^4*, Kazutaka Sunami, MD, PhD⁵, Koji Kato, M.D., Ph.D.^6*, Nobuhiko Uoshima, MD, PhD^7*, Takahiro Kumode, MD, PhD^8*, Ai Ota, BSc^9*, Kaori Mitsuki, MS^10*, Daisuke Yokota, MS^11*, Yuri Sano, MD, PhD¹² and Yasuhito Terui, MD, PhD^13*

¹Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University, Yamagata, Japan
²Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
³Department of Hematology and Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
⁴Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, TKY, Japan
⁵Department of Hematology, National Hospital Organization, Okayama Medical Center, Okayama, Japan
⁶Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
⁷Japanese Red Cross, Kyoto Daini Hospital, Kyoto, JPN
⁸Kindai University, Osakasayama, JPN
⁹Otsuka Pharmaceutical Co.,Ltd., Osaka, OSA, Japan
¹⁰Otsuka Pharmaceutical Co.,Ltd., Minato-Ku, TKY, Japan
¹¹Otsuka Pharmaceutical Co.,Ltd., Osaka, Japan
¹²Otsuka Pharmaceutical Co.,Ltd., Minato-ku, TKY, Japan
¹³Department of Hematology, Saitama Medical University Hospital, Iruma, Japan

Yuqin Song, MD¹, Keshu Zhou, MD^2*, Hongmei Jing, MD³, Jianqiu Wu, PhD^4*, Haiyan Yang^5*, Yu Bai^6*, Ke Fang^6*, Ziyi Liu^6*, Jun Zhu, PhD⁷ and Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc⁸

¹Peking University Cancer Hospital and Institute, Beijing, China
²Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
³Department of Hematology, Peking University Third Hospital, Beijing, China
⁴Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
⁵Zhejiang Cancer Hospital, Hangzhou, China
⁶Dizal Pharmaceutical, Shanghai, China
⁷Peking University Cancer Hospital, Beijing, China
⁸Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

Dustin McCurry, MD¹, Jason Westin, MD², Lei Feng, MS^3*, Sairah Ahmed, MD², Ranjit Nair, MD⁴, Raphael Eric Steiner, MD⁵, Lauren Wynn^6*, Jennifer Thomas^7*, Ly Huynh Dsouza, PA-C^6*, Felipe Samaniego, MD^8*, Sattva S. Neelapu, MD² and Loretta J. Nastoupil, MD²

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Biostatistics, UT MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
⁶Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
⁷UT MD Anderson Cancer Center, Houston, TX
⁸M.D. Anderson Cancer Center, Houston, TX

Henry Ddugnu, MD, PhD^1*, Kelvin Mubiru, MS^2*, Scott V Adams, PhD^3*, Jacqueline Asea, MSN^2*, Joyce Kambugu, MBChB, MMED^1*, Rosemary Namagembe, BSN^2*, Prossy Namuli, BSN^2*, Jackson Orem, MBChB, PhD^1*, Camille Puronen, MD, MPH⁴, Thomas S. Uldrick, MD, MS^3*, Edus H Warren, MD, PhD^5,6 and Manoj P Menon, MD^5,6*

¹Uganda Cancer Institute, Kampala, Uganda
²Hutchinson Center Research Institute of Uganda., Kampala, Uganda
³Fred Hutchinson Cancer Center, Seattle
⁴University of Washington, Seattle
⁵Fred Hutchinson Cancer Center, Seattle, WA
⁶Division of Hematology and Oncology, University of Washington, Seattle, WA

Jia Jin^1*, Yalan Wang^2*, Xi Wang^2*, Yonghong Tang^3*, Shan Zeng^3*, Juan Du⁴ and Junning Cao⁵

¹Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, AL, China
²Department of Lymphoma, Baotou Tumor Hospital, Baotou, Inner Mongolia, China
³Department of Internal Oncology, Xiangya Hospital of Central South University, Changsha, Hunan, China
⁴Department of Lymphoma, Shanghai Changzheng Hospital, Shanghai, China
⁵Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China

Ningjing Lin^1*, Xiuhua Sun^2*, Hui Zhou^3*, Liqun Zou, MD, PhD^4*, Keshu Zhou, MD^5*, Lihong Liu^6*, Haiyan Yang⁷, Kai HU^8*, Qingqing Cai^9*, Yao Liu^10*, Jie Jin, MD¹¹, Liling Zhang^12*, Wenyu Li^13*, Ye Guo^14*, Wei Yang^15*, Feng Luo^16*, Yanyan Li^16*, Mengqi Zhang^16*, Feinan Lu^16*, Yuqin Song^17* and Jun Zhu, PhD¹⁸

¹Department of Lymphatic Oncology, Beijing Cancer Hospital, Beijing, China
²The Second Hospital of Dalian Medical University, Dalian, China
³Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
⁴West China Hospital of Sichuan University, Chengdu, China
⁵Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁶The Fourth Hospital of Hebei Medical University, Hebei, China
⁷Department of Lymphatic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
⁸Department of Adult Lymphoma, Beijing Boren Hospital, Beijing, China
⁹Sun Yat-Sen University Cancer Cente, Guangzhou, China
¹⁰Chongqing University Cancer Hospital, Chongqing, China
¹¹Department of Hematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
¹²Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹³Guangdong Provincial People's Hospital, Guangzhou, China
¹⁴Shanghai East Hospital, Shanghai, China
¹⁵Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
¹⁶Overland Pharmaceuticals, Shanghai, China
¹⁷Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China
¹⁸Peking University Cancer Hospital, Beijing, China

Qingqing Cai, PhD^1*, Yi Xia, M.D, PhD^1*, Liang Wang, M.D, PhD^2*, Huiqiang Huang, MD, PhD¹, Jinni Wang, MSc^1*, Jun Cai, M.D, PhD^1* and Xiaopeng Tian, M.D, PhD^1*

¹Sun Yat-Sen University Cancer Center, Guangzhou, China
²Beijing Tongren Hospital, Capital Medical University, Beijing, China

Thomas M. Habermann, MD¹, Betsy LaPlant, MS^2*, Ivana Micallef, MD^1*, Heidi Diann Finnes, PharmD^3*, Jill Schimke, M.S.^1*, Robin Klebig, MSN, CNP^1*, Nikki Hanley^4*, Rebecca L. King, MD⁵, Thomas E. Witzig, MD¹ and Svetomir Markovic, MD, PhD^6*

¹Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester, Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN
³Department of Pharmacology, Mayo Clinic, Rochester, MN
⁴Mayo Cancer Center, Hematology, Mayo Clinic, Rochester, MN
⁵Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁶Department of Medical Oncology, Mayo Clinic, Rochester, MN

Noriko Fukuhara¹, Yoshitaka Narita, MD, PhD^2*, Motoo Nagane, MD, PhD^3*, Kazuhiko Mishima, MD, PhD^4*, Yasuhito Terui, MD, PhD^5*, Yoshiki Arakawa, MD, PhD^6*, Hajime Yonezawa, MD, PhD^7*, Katsunori Asai, MD, PhD^8*, Kazuhiko Sugiyama, MD, PhD^9*, Naoki Shinojima, MD, PhD^10*, Arata Aoi^11* and Ryo Nishikawa, MD, PhD^12*

¹Department of Hematology and Rheumatology, Tohoku University School of Medicine, Sendai, Japan
²Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, JPN
³Department of Neurosurgery, Kyorin University Faculty of Medicine, Mitaka, TKY, JPN
⁴Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan
⁵Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁶Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
⁷Department of Neurosurgery, Kagoshima University Hospital, Kagoshima, Japan
⁸Department of Neurosurgery, Osaka International Cancer Institute, Osaka, Japan
⁹Department of Clinical Oncology & Neuro-oncology Program, Hiroshima University Hospital, Hiroshima, Japan
¹⁰Department of Neurosurgery, Kumamoto University Hospital, Kumamoto, Japan
¹¹Department of Clinical Development, Ono Pharmaceutical Co., LTD., Osaka, Japan
¹²Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, JPN

Emma Searle^1*, Francesco Forconi^2*, Kim Linton, MD, PhD^3*, Alexey Danilov, MD⁴, Pam McKay^5*, David Lewis, MBChB, PHD^6*, Dima El-Sharkawi, MBBS, FRCPath, PhD^7*, Mary Gleeson^8*, John Riches^9*, Sarah G. Injac^10*, Ted Shih^10*, Srinand Nandakumar^10*, May Tan^10*, Ganesh Cherala^10*, Erin Meredith^10* and Graham P. Collins, MBBS, DPhil¹¹

¹The Christie Hospital and Manchester Cancer Research Centre, Division of Cancer Sciences, Manchester, United Kingdom
²School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
³The Christie Hospital and Manchester Cancer Research Centre, Division of Cancer Sciences, Manchester, GBR
⁴Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA
⁵Haematology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⁶Derriford Hospital, Plymouth, United Kingdom
⁷The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
⁸Sarah Cannon Research Institute and Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
⁹Barts Cancer Institute, London, United Kingdom
¹⁰Nurix Therapeutics, Inc., San Francisco, CA
¹¹Oxford University Hospitals, Oxford, United Kingdom

Alessia Ripamonti, MD^1*, Andrea Aroldi, MD^2*, Federica Cocito, MD^2*, Luca Guerra, MD^3,4*, Lavinia Monaco, MD^4*, Bianca Maria Granelli, MD^3*, Lara Mussolin, PhD^5* and Carlo Gambacorti-Passerini, MD^2,3

¹Department of Medicine and Surgery, University Milano-Bicocca, Alzate Brianza, Italy
²Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
³Department of Medicine and Surgery, University Milano-Bicocca, Monza, Italy
⁴Nuclear Medicine Division, IRCCS San Gerardo dei Tintori, Monza, Italy
⁵Pediatric Hematology-Oncology, University of Padua, Padua, Italy

N. Nora Bennani, MD¹, Pamela Atherton^1*, Kimberly O Steinert^1*, Lisa M. Rimsza, MD², Aung M. Tun, MD³, Marc Hoffmann, MD⁴, Mayur S. Narkhede, MBBS⁵, Rakhee Vaidya, MD^6*, Rabih Said^7*, Geoffrey I Shapiro, MD^8*, Brian A Costello, MD^9*, Stephen M Ansell, MD, PhD¹⁰ and Grzegorz S. Nowakowski, MD¹⁰

¹Mayo Clinic, Rochester, MN
²Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
³Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas, Westwood, KS
⁴The University of Kansas Medical Center, Kansas City, KS
⁵Department of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL
⁶Wake Forest, Winston-Salem, NC
⁷Investigational Drug Branch, CTEP, NCI, Rockville, MD
⁸Dana-Farber Cancer Institute, Boston
⁹Medical Oncology, Mayo Clinic, Rochester, MN
¹⁰Division of Hematology, Mayo Clinic, Rochester, MN